Bausch Health Companies (BHC)Director bought ~$12.7M
John Paulson, Director at Bausch Health Companies, bought ~$12.7M of Bausch Health Companies shares.
- ~$12.7M
- Approx. value · 2M sh @ $6.35
- 34.8M
- Holds after · shares reported
- Traded
- Aug 11, 2025
- Filed
- Aug 13, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Jun 10, 2025InsiderDirector purchased ~$3.81M of BHC shares in the open market
- Jun 11, 2025InsiderDirector purchased ~$5.39M of BHC shares in the open market
- Jun 12, 2025InsiderDirector purchased ~$5.5M of BHC shares in the open market
- Jun 13, 2025InsiderDirector purchased ~$21.2M of BHC shares in the open market
- Aug 11, 2025 · this disclosureInsiderDirector purchased ~$12.7M of BHC shares in the open market
What came next
- Aug 12, 2025InsiderDirector purchased ~$7.96M of BHC shares in the open market
- Aug 13, 2025InsiderDirector purchased ~$610K of BHC shares in the open market
- Aug 14, 2025InsiderDirector purchased ~$312M of BHC shares in the open market
- Aug 21, 2025InsiderDirector sold ~$122K of BHC shares in the open market
- Sep 8, 2025InsiderOfficer sold ~$98K of BHC shares in the open market
- Oct 29, 2025Company filing · Form 8-K · ResultsReported its results
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Bausch Health Companies
For Bausch Health Companies, OQRO holds 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BHC page.
Other recent filings by John Paulson, Director
- SEC Form 4 at Bausch Health Companies (BHC)Aug 15, 2025
- SEC Form 4 at Bausch Health Companies (BHC)Aug 13, 2025
- SEC Form 4 at Bausch Health Companies (BHC)Aug 13, 2025
- SEC Form 4 at Bausch Health Companies (BHC)Jun 17, 2025
- SEC Form 4 at Bausch Health Companies (BHC)Jun 13, 2025
The full history of John Paulson, Director is on the profile page.
How this filing works
Other disclosures at Bausch Health Companies
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRMay 15, 2026
- SEC Form 13F-HRMay 15, 2026
- SEC Form 13F-HRFeb 17, 2026
- SEC Form 13F-HRFeb 17, 2026
- SEC Form 13F-HRFeb 13, 2026
Everything OQRO holds on this company is on its BHC page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
